- Lobbying
- Lobbying by Otsuka Pharmaceutical Development & Commercialization, Inc.
Lobbying Relationship
Bills mentioned
S.1945: Mental Health Reform Act of 2015
Sponsor: Bill Cassidy (R-La.)
S.481: Improving Regulatory Transparency for New Medical Therapies Act
Sponsor: Orrin G. Hatch (R-Utah)
S.1893: Mental Health Awareness and Improvement Act of 2015
Sponsor: Lamar Alexander (R-Tenn.)
H.R.2624: Part D Beneficiary Appeals Fairness Act
Sponsor: Hank Johnson (D-Ga.)
H.R.2646: Helping Families in Mental Health Crisis Act of 2016
Sponsor: Tim Murphy (R-Pa.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.9: Innovation Act
Sponsor: Robert W. Goodlatte (R-Va.)
H.R.639: Improving Regulatory Transparency for New Medical Therapies Act
Sponsor: Joe Pitts (R-Pa.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Heide Bajnrauh | Intrn, Sen McCain, 94-96; LSA, 96-97 |
Todd Tuten | Rep Michael Bilirakis; 91-92, 93-95, 98-01 |
Molly Ryan | n/a |
Richard Thompson | n/a |
John Jonas | n/a |
Karen Thiel | n/a |
Eli Tomar | n/a |
John Bardi | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate